Newly Diagnosed Multiple Myeloma is Associated with Hypercoagulablity and High Risk of VTE. The Roadmap Study

被引：0
|
作者：
Fotiou, Despina [1 ]
Gerotziafas, Grigorios [2 ]
Zagouri, Flora [3 ]
Sergentanis, Theodoros [3 ]
机构：
[1] Alexandra Hosp, Oncol & Hematol Dept, Athens, Greece
[2] Tenon Univ Hosp, Fac Med Pierre Marie Curie, Serv Hematol Biol, Paris, France
[3] Natl & Kapodistrian Univ Athens, Dept Clin Therapeut, Athens, Greece
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷 / 01期
关键词：
D O I：
10.1016/j.clml.2017.03.174
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS-172
引用
收藏
页码：E97 / E97
页数：1
相关论文
共 50 条
  • [21] Newly diagnosed multiple myeloma.
    Weber D.M.
    Current Treatment Options in Oncology, 2002, 3 (3) : 235 - 245
  • [22] Bortezomib in newly diagnosed multiple myeloma
    James R. Berenson
    Nature Reviews Clinical Oncology, 2009, 6 : 255 - 256
  • [23] Treatment of newly diagnosed multiple myeloma
    Palumbo A.
    Magarotto V.
    Larocca A.
    Bringhen S.
    Falco P.
    Di Raimondo F.
    Baldini L.
    Boccadoro M.
    Current Hematologic Malignancy Reports, 2008, 3 (2) : 107 - 114
  • [24] Bortezomib in newly diagnosed multiple myeloma
    Berenson, James R.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (05) : 255 - 256
  • [25] Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma
    Leypoldt, Lisa B.
    Tichy, Diana
    Besemer, Britta
    Haenel, Mathias
    Raab, Marc S.
    Mann, Christoph
    Munder, Markus
    Reinhardt, Hans Christian
    Nogai, Axel
    Goerner, Martin
    Ko, Yon-Dschun
    de Wit, Maike
    Salwender, Hans
    Scheid, Christof
    Graeven, Ullrich
    Peceny, Rudolf
    Staib, Peter
    Dieing, Annette
    Einsele, Hermann
    Jauch, Anna
    Hundemer, Michael
    Zago, Manola
    Pozek, Ema
    Benner, Axel
    Bokemeyer, Carsten
    Goldschmidt, Hartmut
    Weisel, Katja C.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (01) : 26 - +
  • [26] VRd vs. VPd as induction therapy in high risk newly diagnosed multiple myeloma
    Li, Chun Yan
    Zhong, Long
    Chen, Dan Gui
    Yao, Fu Sheng
    Yan, Hong
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [27] Myeloma: management of the newly diagnosed high-risk patient
    Dispenzieri, Angela
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 485 - 494
  • [28] Substratification of patients with newly diagnosed standard-risk multiple myeloma
    Binder, Moritz
    Rajkumar, S. Vincent
    Ketterling, Rhett P.
    Dispenzieri, Angela
    Lacy, Martha Q.
    Gertz, Morie A.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Hwa, Yi L.
    Zeldenrust, Steven R.
    Lust, John A.
    Russell, Stephen J.
    Leung, Nelson
    Kapoor, Prashant
    Go, Ronald S.
    Gonsalves, Wilson I.
    Kyle, Robert A.
    Kumar, Shaji K.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (02) : 254 - 260
  • [29] Underweight as a risk factor of mortality in patients with newly diagnosed multiple myeloma
    Chun-Kuang Tsai
    Chiu-Mei Yeh
    Te-Lin Hsu
    Chia-Ju Li
    Chian Tin
    Liang-Tsai Hsiao
    Yao-Chung Liu
    Hao-Yuan Wang
    Po-Shen Ko
    Po-Min Chen
    Jin-Hwang Liu
    Jyh-Pyng Gau
    Chia-Jen Liu
    Supportive Care in Cancer, 2021, 29 : 3991 - 3999
  • [30] Risk Factors for Renal Failure in Patients with Newly Diagnosed Multiple Myeloma
    Fuentes-Lacouture, Maria C.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 : S28 - S29
12345